227 related articles for article (PubMed ID: 10877872)
1. Finasteride revisited: Proscar for the prostate and Propecia for the pate.
Harv Mens Health Watch; 2000 Jul; 4(12):1-4. PubMed ID: 10877872
[No Abstract] [Full Text] [Related]
2. Finasteride and minoxidil for alopecia revisited.
Med Lett Drugs Ther; 2005 Nov; 47(1222):95-6. PubMed ID: 16299452
[No Abstract] [Full Text] [Related]
3. Propecia and Rogaine Extra Strength for alopecia.
Med Lett Drugs Ther; 1998 Feb; 40(1021):25-7. PubMed ID: 9505960
[No Abstract] [Full Text] [Related]
4. Finasteride in benign prostatic hyperplasia.
Verhamme KM; Bosch RJ; Sturkenboom MC
N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15049034
[No Abstract] [Full Text] [Related]
5. Treatment of benign prostatic hyperplasia.
Walsh PC
N Engl J Med; 1996 Aug; 335(8):586-7. PubMed ID: 8678937
[No Abstract] [Full Text] [Related]
6. [5-alpha reductase inhibitors or alpha blockers? The combination brakes best prostatic hyperplasia].
MMW Fortschr Med; 2002 Oct; 144(44):56. PubMed ID: 12494605
[No Abstract] [Full Text] [Related]
7. Minoxidil vs finasteride in the treatment of men with androgenetic alopecia.
Saraswat A; Kumar B
Arch Dermatol; 2003 Sep; 139(9):1219-21. PubMed ID: 12975174
[No Abstract] [Full Text] [Related]
8. [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination].
Hausmann R; Thalmann G; Reich O; Steif CG
Aktuelle Urol; 2004 Sep; 35(5):339-42. PubMed ID: 15383991
[No Abstract] [Full Text] [Related]
9. [Long-term results of proscar (finasteride, MSD) treatment of patients with benign prostatic hyperplasia].
Tkachuk VN; Al'-Shukri SKh; Kornienko VI; Kuz'min IV
Urol Nefrol (Mosk); 1998; (4):37-9. PubMed ID: 9727320
[TBL] [Abstract][Full Text] [Related]
10. Terazosin vs finasteride for BPH.
Zacks M
J Fam Pract; 1996 Dec; 43(6):533. PubMed ID: 8969692
[No Abstract] [Full Text] [Related]
11. Advances in the medical management of benign prostatic hyperplasia.
Jewett MA; Klotz LH;
CMAJ; 2007 Jun; 176(13):1850-1. PubMed ID: 17576985
[No Abstract] [Full Text] [Related]
12. Re: an economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.
DiSantostefano RL; Biddle AK; Lavelle JP
Can J Urol; 2005 Feb; 12(1):2508-9; author reply 2509-10. PubMed ID: 15777487
[No Abstract] [Full Text] [Related]
13. Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride.
Walsh DS; Dunn CL; James WD
Arch Dermatol; 1995 Dec; 131(12):1373-5. PubMed ID: 7492124
[No Abstract] [Full Text] [Related]
14. Benign prostatic hyperplasia (BPH).
Harv Mens Health Watch; 2006 Aug; 11(1):3. PubMed ID: 17111474
[No Abstract] [Full Text] [Related]
15. [Treatment of benign prostatic hypertrophy].
Romics I
Orv Hetil; 2003 Nov; 144(45):2229-30. PubMed ID: 14686009
[No Abstract] [Full Text] [Related]
16. [Drugs for prostatic adenoma].
Portet-Brunet L
Soins; 1995 Oct; (599):69-70. PubMed ID: 8701357
[No Abstract] [Full Text] [Related]
17. Benign prostatic hyperplasia.
Doherty AP
Hosp Med; 2003 Feb; 64(2):114. PubMed ID: 12619342
[No Abstract] [Full Text] [Related]
18. Therapeutic hotline. Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction?
Lynn R; Krunic A
Dermatol Ther; 2010; 23(5):544-6. PubMed ID: 20868409
[TBL] [Abstract][Full Text] [Related]
19. Medical treatment as an alternative to surgery in the management of benign prostatic hypertrophy.
Bredin HC
Ir Med J; 1996; 89(3):86, 88. PubMed ID: 8707527
[No Abstract] [Full Text] [Related]
20. Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal.
Tosti A; Iorizzo M; Vincenzi C
Arch Dermatol; 2003 Sep; 139(9):1221-2. PubMed ID: 12975176
[No Abstract] [Full Text] [Related]
[Next] [New Search]
